Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy

Kisspeptin-10 + Epitalon + BPC-157 + GHK-Cu Menopause Support Stack

A community-derived peptide combination sometimes discussed for the constellation of complaints around the menopausal transition — hot flashes, sleep disruption, bone loss, mood changes, and skin thinning. It is a mechanistic rationale, not a proven therapy, and is not a substitute for hormone replacement therapy or clinician-directed care.

Quick Comparison

PropertypeptideThe Menopause Support Stack: Kisspeptin-10 + Epitalon + BPC-157 + GHK-Cu
SourceSalmon DNA fragmentsVarious sources
Primary MechanismA2A receptor activation, DNA repairVaries by ingredient
Key BenefitsTissue regeneration, anti-inflammation, collagen boostMultiple skin benefits
Best Time to ApplyAM or PMAM or PM
Can Combine?Generally compatible — check specific guidelines.

How to Use Together

There is no validated protocol for this combination; the peptides are research compounds and no controlled trial has tested them together for menopause. Representative community approaches: Epitalon 5–10 mg subcutaneously daily in short cycles (e.g., 10–20 days, one to two cycles per year) as a putative circadian/pineal regulator; BPC-157 250–500 mcg subcutaneously daily for connective-tissue and gut support during defined 4–6 week runs; GHK-Cu is most conventionally used topically (as a copper-peptide cosmetic serum) for skin thinning rather than injected. Kisspeptin-10 acts upstream on the GnRH axis and is investigational — its use in an already low-estrogen menopausal state is theoretical and should only be considered under specialist supervision. Any hormonal endpoint (hot flashes, cycle changes) should be managed first with evidence-based options through a clinician.

Safety Notes

This is not a replacement for menopausal hormone therapy (MHT/HRT), which remains the standard of care with the strongest evidence for vasomotor symptoms and bone protection; peptides do not replicate estrogen's effects on bone density, cardiovascular risk, or genitourinary tissue. Kisspeptin influences the hypothalamic-pituitary-gonadal axis and its effects in postmenopausal physiology are poorly characterized — avoid in anyone with a history of hormone-sensitive cancer until discussed with an oncologist and gynecologist. GHK-Cu can cause contact irritation topically; injected copper peptides carry copper-accumulation concerns and are not advised for people with Wilson's disease. BPC-157 and Epitalon are research-only with no long-term human safety data. Bone loss, cardiovascular risk, and mood disorders during menopause warrant formal medical evaluation, not self-directed peptide experimentation.

Recommended Products (4)

Frequently Asked Questions

Is this stack a replacement for hormone replacement therapy (HRT)?
No. Menopausal hormone therapy is the best-evidenced treatment for hot flashes, night sweats, and bone loss, and none of these peptides replicate estrogen's actions on bone, the cardiovascular system, or vaginal tissue. This combination is a speculative adjunct at best and should never be used to postpone or replace a discussion about HRT with a qualified clinician. If your primary concern is vasomotor symptoms or osteoporosis prevention, standard-of-care hormonal or non-hormonal options should be your starting point, not research peptides.
What is the rationale for each peptide in this menopause stack?
Kisspeptin-10 sits upstream of the reproductive hormone axis and is studied for its role in GnRH signaling, which is why it appears in fertility and hormonal discussions. Epitalon is a pineal-derived tetrapeptide proposed to support circadian rhythm and sleep, a common menopausal complaint. BPC-157 is a repair peptide used for gut and connective tissue, and GHK-Cu is a copper peptide with cosmetic evidence for skin firmness and thickness. The rationale is that each targets a different menopausal symptom cluster — but this is a theoretical assembly, not a synergy demonstrated in any trial.
Can kisspeptin help with menopausal hot flashes?
The relationship is complicated and not established. Kisspeptin neurons interact with the neurokinin B/KNDy system that drives hot flashes, and it is that upstream system — not kisspeptin supplementation itself — that has become a drug target (neurokinin-3 receptor antagonists like fezolinetant are the actual approved approach for hot flashes). Giving kisspeptin-10 in menopause has not been shown to relieve vasomotor symptoms and could theoretically have unpredictable effects. If hot flashes are your concern, ask a clinician about proven hormonal and non-hormonal medications rather than investigational peptides.
Does this stack protect bone density during menopause?
There is no evidence that it does, and this is an important limitation. Postmenopausal bone loss is driven by estrogen decline, and the proven protections are estrogen therapy, adequate calcium and vitamin D, weight-bearing and resistance exercise, and — where indicated — bisphosphonates or other bone medications. None of the peptides in this stack has human data showing they preserve bone mineral density. Anyone concerned about osteoporosis should get a DEXA scan and follow an evidence-based bone-health plan with their doctor.
Has any clinical trial tested this combination for menopause?
No controlled trial has tested this four-peptide combination for menopausal symptoms, and most of these compounds are research-only with limited or no human data in this context. What exists is mechanistic reasoning and anecdotal community reports, which are not a substitute for controlled evidence. You should treat any claims about this stack's effectiveness as unproven. The honest framing is that it is an experimental idea, and the standard-of-care options for menopause have decades of trial data behind them.
Why is GHK-Cu usually recommended topically rather than injected here?
GHK-Cu's best human evidence is cosmetic — topical copper-peptide formulations have data for improving skin firmness, thickness, and the appearance of fine lines, which is directly relevant to the skin thinning many people notice around menopause. Injecting copper peptides raises concerns about systemic copper handling and offers no comparable evidence for menopausal benefit. For skin-related menopausal changes, a well-formulated topical GHK-Cu serum is the more sensible and better-supported route. Reserve any systemic use for discussion with a knowledgeable clinician.
Could this stack help with menopausal sleep and mood problems?
The rationale for Epitalon is its proposed circadian and pineal effects, and better sleep can indirectly improve mood, but human evidence for Epitalon improving menopausal insomnia specifically is lacking. Menopausal sleep disruption is often driven by night sweats, so treating vasomotor symptoms (via HRT or non-hormonal medication) frequently resolves the sleep issue at its source. Mood changes in menopause can also reflect clinical depression or anxiety that deserve proper assessment. If sleep and mood are significantly affecting your life, a clinician evaluation is more likely to help than a research peptide.
Is kisspeptin safe for someone with a history of breast cancer?
This warrants extra caution and specialist input. Kisspeptin acts on the reproductive hormone axis, and anything that could influence sex-hormone signaling deserves careful review in people with a history of hormone-sensitive cancers such as many breast cancers. There is no reassurance data here, so the conservative and appropriate step is to avoid it unless an oncologist and gynecologist have specifically reviewed your situation. This is a clear example of why self-directed use of hormonally active peptides is risky without medical oversight.
What lifestyle factors matter most during the menopausal transition?
The foundations with the strongest evidence are resistance and weight-bearing exercise to protect bone and muscle, adequate protein (roughly 1.2–1.6 g/kg) to counter age-related muscle loss, sufficient calcium and vitamin D, good sleep hygiene, limiting alcohol and managing caffeine (both worsen hot flashes and sleep), and not smoking. These interventions are free, well-studied, and address the same symptom clusters this stack targets — often more reliably. Peptides, if used at all, should sit on top of these fundamentals rather than substitute for them, and a clinician should coordinate the overall plan.
Are these peptides legal and available as approved menopause treatments?
None of these four peptides is an approved menopause treatment in major jurisdictions; they are generally sold as research chemicals rather than prescription therapies, and their regulatory status varies by country. That means quality, purity, and dosing accuracy are not guaranteed the way they are for approved medications. Using them for menopause is off-label and experimental. Approved menopause treatments — hormonal and non-hormonal — are available by prescription and are the appropriate first line, so discuss those with your clinician before considering any research compound.

Other peptide Ingredient Combinations

The Anti-Aging Stack: GHK-Cu + Epitalon

GHK-Cu and Epitalon target two distinct hallmarks of aging — extracellular matrix degradation and te

The Athletic Performance Stack: IGF-1 LR3 + Ipamorelin + BPC-157

The athletic performance stack layers three peptides with distinct but complementary mechanisms to s

The Autoimmune Stack: KPV + BPC-157 + Thymosin Alpha-1 + Low-Dose Naltrexone

A four-component protocol addressing autoimmune dysregulation through complementary immunomodulatory

The Bone Health Stack: BPC-157 + Abaloparatide + Collagen Peptides

A three-component protocol addressing bone mineral density and bone quality. Abaloparatide is a synt

The Cardiac Protection Stack: TB-500 + SS-31 + Humanin

A three-peptide cardiovascular support stack targeting myocardial repair (TB-500), mitochondrial car

The Cognitive Stack: Semax + Selank

The classic Russian nootropic peptide pairing. Semax (an ACTH 4-10 analog) enhances BDNF expression

The Detox Support Stack: BPC-157 + KPV + LL-37 + Larazotide

A four-peptide combination addressing gut barrier integrity, systemic inflammation, and antimicrobia

The Endurance Stack: MOTS-c + SS-31 + BPC-157 + AOD-9604

A community-derived peptide combination discussed by endurance athletes for mitochondrial capacity,

The Eye Health Stack: Thymosin Beta-4 + BPC-157 + SS-31 + GHK-Cu

A theoretical peptide combination discussed for ocular surface and retinal support — dry eye, cornea

The Fat Loss Stack: Tesamorelin + CJC-1295/Ipamorelin

Tesamorelin and CJC-1295/Ipamorelin both target the GH axis but through complementary timing and rec

The Fertility Stack: Kisspeptin-10 + Gonadorelin + Oxytocin

A three-peptide protocol targeting the hypothalamic-pituitary-gonadal (HPG) axis at multiple levels.

The GH Stack: CJC-1295 + Ipamorelin

The dual-pathway growth-hormone stack. CJC-1295 (GHRH analog) opens the pituitary somatotroph; Ipamo

The Gut-Brain Stack: BPC-157 + KPV + Selank + Larazotide

A community-derived peptide combination built around the gut-brain axis — pairing intestinal barrier

The Gut Healing Stack: BPC-157 + KPV + Larazotide

The gut healing stack combines three peptides targeting distinct aspects of intestinal repair: BPC-1

The Hair Restoration Stack: GHK-Cu + Thymosin Beta-4

GHK-Cu and Thymosin Beta-4 (TB-500) target complementary mechanisms in hair follicle biology — coppe

The Healing Stack: BPC-157 + TB-500

The canonical regenerative-peptide pairing. BPC-157 and TB-500 operate through non-overlapping biolo

Immune Support Stack

A combination approach targeting immune function through three complementary mechanisms: adaptive im

The Joint Repair Stack: BPC-157 + Pentosan Polysulfate + TB-500

A comprehensive joint-repair protocol targeting all layers of joint pathology: BPC-157 for periartic

The Longevity Stack: Epitalon + MOTS-c + SS-31

Three peptides targeting different hallmarks of aging: Epitalon for telomerase activation and pineal

The Men's Hormone Stack: CJC-1295/Ipamorelin + Gonadorelin + Kisspeptin-10

A three-peptide protocol designed to optimize the male hormonal axis without exogenous testosterone.

The Metabolic Stack: GLP-1 + GHS

A newer 'metabolic recomposition' pairing some practitioners use: a GLP-1 agonist for appetite and t

The Mitochondrial Stack: SS-31 + MOTS-c + Humanin

Three mitochondria-targeted peptides addressing different aspects of mitochondrial dysfunction. SS-3

The Mood & Anxiety Stack: Selank + NA-Selank-Amidate + DSIP + Oxytocin

A four-peptide anxiolytic and mood-stabilizing protocol. Selank modulates GABA and serotonin signali

The Neuroprotection Stack: Cerebrolysin + Semax + Pinealon

The neuroprotection stack combines three neuropeptide approaches with complementary mechanisms — cer

The Nootropic Stack: Semax + Selank + GH-Axis Support

A three-tier nootropic peptide stack targeting cognitive performance through complementary mechanism

The Post-Surgery Recovery Stack: BPC-157 + TB-500 + Thymosin Alpha-1

The post-surgery recovery stack combines the established BPC-157 + TB-500 tissue-repair pairing with

The Sexual Health Stack: PT-141 + Kisspeptin-10

PT-141 and Kisspeptin-10 target complementary aspects of sexual function — central desire pathways a

The Skin Rejuvenation Stack: GHK-Cu + GH-Axis + Collagen

A multi-level skin rejuvenation protocol combining topical signaling (GHK-Cu), systemic GH-axis elev

The Sleep Stack: DSIP + Ipamorelin

DSIP (Delta Sleep-Inducing Peptide) and ipamorelin target complementary aspects of sleep optimizatio

The Stress Resilience Stack: Selank + DSIP + Semax

A three-peptide stack targeting different dimensions of the stress response: Selank for anxiolysis a

The Tendon Repair Stack: BPC-157 + TB-500 + GHK-Cu

A three-peptide protocol targeting tendon biology specifically. BPC-157 upregulates growth hormone r

The Thymic Regeneration Stack: Thymosin Alpha-1 + Thymalin + Thymulin

Three thymic peptides targeting the age-related involution of the thymus gland. Thymosin alpha-1 enh

The Vascular Health Stack: BPC-157 + SS-31 + Angiotensin-1-7 + MOTS-c

A theoretical peptide combination discussed for endothelial and circulatory support — pairing angiog

The Weight Loss Stack: Semaglutide/Tirzepatide + Tesamorelin

This weight loss stack combines GLP-1 receptor agonist therapy (semaglutide or tirzepatide) with the

The Women's Hormonal Stack: Kisspeptin + BPC-157 + Thymosin Alpha-1

A three-peptide combination addressing women's hormonal health through hypothalamic signaling restor

The Wound Care Stack: BPC-157 + GHK-Cu + TB-500 + Collagen Peptides

A four-component protocol covering the full wound healing cascade. BPC-157 promotes angiogenesis and

Browse All peptide Products

Search

Search across products, blog posts, wiki articles, and more.